Literature DB >> 18795590

Echocardiography and the clinical diagnosis of left ventricular dysfunction.

Daniele Rovai1, Maria-Aurora Morales, Gianluca Di Bella, Renato Prediletto, Michele De Nes, Alessandro Pingitore, Giuseppe Rossi.   

Abstract

INTRODUCTION: The added value of routine echocardiography, in respect to clinical examination and ECG, has received little attention. We sought to evaluate the contribution of two-dimensional echocardiography, in respect to clinical examination and ECG, in detecting left ventricular (LV) dilatation and systolic dysfunction.
METHOD: A group of 100 patients, scheduled for cardiac magnetic resonance imaging (MRI), was prospectively studied.
RESULTS: Clinical examination identified moderate-to-severe LV dysfunction, defined as a LV ejection fraction (EF) < 45% at MRI, with a sensitivity of 62% and a specificity of 68%. After ECG, sensitivity and specificity slightly improved (71 and 70%, respectively). After the echocardiographic report, sensitivity reached 84% and specificity 90%. LV EF by echocardiography (routine studies) was closely related with that by MRI (r = 0.84). LV function was scored as undefined in 17% of patients after clinical examination, in 5% of patients after ECG and in no patient after echocardiography (P < 0.0001). Clinical examination identified patients with LV dilatation (LV end-diastolic volume > or = 110 ml/m2) with a poor sensitivity (33%) but a good specificity (88%). After ECG, sensitivity was 39% and specificity 87%; after echocardiography, sensitivity reached 53% and specificity 92%.
CONCLUSION: Echocardiography provides information on LV function and dimensions that vastly exceeds that obtained by clinical examination and ECG. This study supports the use of echocardiography to improve patient diagnosis and management after history and physical examination.

Entities:  

Mesh:

Year:  2008        PMID: 18795590     DOI: 10.2143/AC.63.4.2033051

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN: 0001-5385            Impact factor:   1.718


  6 in total

Review 1.  Handcarried echocardiography to assess hemodynamics in acute decompensated heart failure.

Authors:  Sascha N Goonewardena; Kirk T Spencer
Journal:  Curr Heart Fail Rep       Date:  2010-12

Review 2.  Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

Authors:  Saro H Armenian; Melissa M Hudson; Renee L Mulder; Ming Hui Chen; Louis S Constine; Mary Dwyer; Paul C Nathan; Wim J E Tissing; Sadhna Shankar; Elske Sieswerda; Rod Skinner; Julia Steinberger; Elvira C van Dalen; Helena van der Pal; W Hamish Wallace; Gill Levitt; Leontien C M Kremer
Journal:  Lancet Oncol       Date:  2015-03       Impact factor: 41.316

3.  Cost-effectiveness of the children's oncology group long-term follow-up screening guidelines for childhood cancer survivors at risk for treatment-related heart failure.

Authors:  F Lennie Wong; Smita Bhatia; Wendy Landier; Liton Francisco; Wendy Leisenring; Melissa M Hudson; Gregory T Armstrong; Ann Mertens; Marilyn Stovall; Leslie L Robison; Gary H Lyman; Steven E Lipshultz; Saro H Armenian
Journal:  Ann Intern Med       Date:  2014-05-20       Impact factor: 25.391

4.  Walking with Gianluca Di Bella during the development of clinical cardiac imaging.

Authors:  Gianluca Di Bella
Journal:  World J Cardiol       Date:  2010-11-26

5.  Assessment of cardiac pathology by point-of-care ultrasonography performed by a novice examiner is comparable to the gold standard.

Authors:  Christian Alcaraz Frederiksen; Peter Juhl-Olsen; Niels Holmark Andersen; Erik Sloth
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2013-12-13       Impact factor: 2.953

6.  Junior medical student performed focused cardiac ultrasound after brief training to detect significant valvular heart disease.

Authors:  Bryan P Yan; Jacquelyn Chi-Ying Fok; Teddy Hong-Yee Wong; Gary Tse; Alex P W Lee; Xing-Sheng Yang; Jing-Ping Sun
Journal:  Int J Cardiol Heart Vasc       Date:  2018-05-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.